Lu AA41063

Lu AA41063 is a selective adenosine A 2A receptor antagonist.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Lu AA41063 is a selective adenosine A 2A receptor antagonist. Structurally, it is a non-xanthine.

The affinities (K i ) of the drug for the human adenosine receptors are 5.9 nM for the adenosine A 2A receptor, 410 nM for the adenosine A 1 receptor (69-fold lower than for the A 2A receptor), 260 nM for the adenosine A 2B receptor (44-fold lower than for the A 2A receptor), and >10,000 nM for the adenosine A 3 receptor (>1,695-fold lower than for the A 2A receptor). Lu AA41063 was first described in the scientific literature by 2014.

Lu AA47070, a water-soluble phosphate ester prodrug of Lu AA41063, is orally active and was under development for the treatment of Parkinson's disease but was discontinued. In addition to its antiparkinsonian-like effects, Lu AA47070 reverses motivational deficits in animals and hence shows pro-motivational effects.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1328680959 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

1 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.